AC
ONCE

Amici Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Amici Capital’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-15,000
Closed -$443K – 136
2016
Q1 		$443K Buy
+15,000
New +$473K 0.05% 94

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Amici Capital's ONCE Position: Q2 2016 in Review

Amici Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2016, closing a stake of 15,000 shares — an estimated $443K sold.

Amici Capital first reported a position in ONCE in Q1 2016 and held it in 1 quarter. The position peaked at $443K in Q1 2016. 115 funds tracked by Wall St. Rank hold ONCE as of Q2 2016.

  • Amici Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Amici Capital sold 15,000 Spark Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $443K.
  • Amici Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and held it in 1 quarter.
  • Amici Capital's Spark Therapeutics, Inc. Common Stock position peaked at $443K in Q1 2016.
  • 115 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Amici Capital's 13F filing for Q2 2016, filed 15 Aug 2016.